Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI

[1]  B. G. Brown,et al.  Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. , 1991, Journal of lipid research.

[2]  S. Eisenberg,et al.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.

[3]  R. Krauss,et al.  Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  B. Paigen,et al.  Synthetic low and high fat diets for the study of atherosclerosis in the mouse. , 1990, Journal of lipid research.

[5]  B. Paigen,et al.  Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. , 1990, Arteriosclerosis.

[6]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[7]  B. Paigen,et al.  Ath-2, a second gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. , 1989, Genetics.

[8]  J. Breslow,et al.  High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. , 1989, The Journal of biological chemistry.

[9]  E. Skamene,et al.  ATH-3, a new gene for atherosclerosis in the mouse. , 1989, Clinical and investigative medicine. Medecine clinique et experimentale.

[10]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[11]  L. Rudel,et al.  Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet-induced hypercholesterolemia. , 1988, The Journal of biological chemistry.

[12]  R. Williams,et al.  Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.

[13]  A. Lusis,et al.  Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  N. Miller.  Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. , 1987, American heart journal.

[15]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[16]  R. Krauss,et al.  Nondenaturing polyacrylamide gradient gel electrophoresis. , 1986, Methods in enzymology.

[17]  H. Mcgill,et al.  George Lyman Duff memorial lecture. Persistent problems in the pathogenesis of atherosclerosis. , 1984, Arteriosclerosis.

[18]  A. Gotto,et al.  Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Grillo,et al.  Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. , 1981, Clinical chemistry.

[20]  L. Rudel,et al.  Determination of cholesterol using o-phthalaldehyde. , 1973, Journal of lipid research.